Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.38 SEK | +0.31% | +2.90% | -12.36% |
Mar. 25 | Senzagen Receives Follow-Up Order Worth SEK 0.8 Million from the Global Chemicals Leader | CI |
Mar. 22 | SenzaGen AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 67.55M 6.2M | Sales 2025 * | 91.65M 8.42M | Capitalization | 154M 14.17M |
---|---|---|---|---|---|
Net income 2024 * | -15M -1.38M | Net income 2025 * | -4M -367K | EV / Sales 2024 * | 2.17 x |
Net cash position 2024 * | 8M 735K | Net cash position 2025 * | 9M 826K | EV / Sales 2025 * | 1.59 x |
P/E ratio 2024 * |
-10.3
x | P/E ratio 2025 * |
-37.5
x | Employees | 34 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.56% |
Latest transcript on SenzaGen AB
1 day | +0.31% | ||
1 week | +2.90% | ||
Current month | -4.49% | ||
1 month | -4.49% | ||
3 months | -2.15% | ||
6 months | -12.36% | ||
Current year | -12.36% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Nählstedt
CEO | Chief Executive Officer | 50 | 17-12-31 |
Marianne Olsson
DFI | Director of Finance/CFO | 63 | 16-10-31 |
Henrik Johansson
CTO | Chief Tech/Sci/R&D Officer | 42 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 76 | 10-08-17 | |
Director/Board Member | 59 | 14-10-14 | |
Paula Zeilon
BRD | Director/Board Member | 62 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 6.38 | +0.31% | 10,070 |
24-04-25 | 6.36 | -0.31% | 33,003 |
24-04-24 | 6.38 | 0.00% | 24,456 |
24-04-23 | 6.38 | +2.90% | 82,499 |
24-04-22 | 6.2 | 0.00% | 13,251 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 11:29 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.36% | 14.08M | |
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 383M |
- Stock Market
- Equities
- SENZA Stock